In the Wisconsin Sleep Cohort, among 1,522 patients followed for 18 years, patients with untreated OSA had five times the risk of CV events when compared with those without OSA. 14 In the Sleep Heart Health Study (SHHS), a cross-sectional analysis involving 6, 424 patients with sleep studies, OSA was identified as an independent risk factor for CV disease. 15 Furthermore, OSA is associated with a higher risk of hypertension, left ventricular hypertrophy and early atherosclerosis. [16] [17] [18] Among patients with heart failure, OSA and AF are associated with a poor response to cardiac resynchronisation therapy and increased mortality. 19, 20 Is Obstructive Sleep Apnoea a Risk Factor for AF in the General Population?
OSA and AF share common risk factors and are independently associated with similar adverse outcomes, but it has not been proved that OSA causes AF. Several prospective analyses have assessed the association between OSA and AF. In the SHHS, it was observed that OSA/sleep-disordered breathing increased AF risk fourfold, after adjusting for confounders. 15 These findings were confirmed by a recent meta-analysis of patients who had coronary artery bypass surgery. 21 In another analysis of 3,542 patients who received a sleep study, Gami et al. demonstrated a relationship between OSA severity and AF. 22 OSA was associated with a 1.3-fold increase in the risk of AF for every 1-point increase in apnoea-hypopnea index (AHI). This association remained robust in people over the age of 65 years. 22 Previous studies have also reported an association between OSA severity and AF frequency, AF persistence and treatment efficacy. 
Mechanism of AF in Patients with Obstructive Sleep Apnoea
There are several possible explanations for the triggers and substrate of AF: the multiple wavelet theory where multiple wavelets of activation coalesce and spread across the atrium; spontaneous pulmonary vein ectopy; atrial sources of repetitive spiralling activity referred to as rotors; and focal sources of rapid activation.
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Intramural micro re-entry enabled by discontinuous atrial myocardial fibres and anatomic or functional conduction barriers help to explain the substrate that maintains AF. [35] [36] [37] Several other factors such as hypoxia, hypercapnia, fluctuations in autonomic tone, atrial stretch and inflammatory factors may contribute to the pathogenesis of AF alongside OSA.
Hypoxia/Hypercapnia as Triggers to AF in Patients with Obstructive Sleep Apnoea
Patients with poorly controlled OSA have repetitive episodes of hypoxia/hypercapnia while experiencing apnoea, and then normal oxygenation when woken up by the episode. These repetitive episodes form an electrophysiological milieu for AF generation. Animal studies have shown that hypoxic periods enable slow atrial conduction and increased atrial refractoriness. 38, 39 Hypercapnia that accompanies hypoxic episodes accentuates these atrial conduction changes. 38 Clinical studies have shown that the magnitude of nocturnal desaturation is proportional to the risk of AF, and there is a relationship between the severity of OSA and the risk of AF (AHI 5-15 is associated with a twofold higher risk of AF, whereas AHI >15 is associated with an almost sixfold higher risk of AF). 40, 41 These data add strength to the hypoxia/hypercapnia theory of AF in patients with OSA.
Autonomic Nervous System Modulation in AF
Repetitive episodes of apnoea which wake up patients with OSA stimulates the sympathetic nervous system and can cause catecholamine surges. 42 This stimulates the renin-angiotensin-aldosterone system which in turn leads to fluid retention. Parapharyngeal fluid collection seems to accentuate OSA. 42 Hence, patients with OSA go through a vicious circle of autonomic nervous system stimulation, fluid retention and worsening OSA.
In our previous work, in support of this hypothesis, we showed that renal sympathetic denervation, a therapeutic modality that severs sympathetic nerves around the kidney, had the potential to reduce the AHI and hence improve OSA. 42 The autonomic nervous system perturbations also increase blood pressure and cardiac afterload.
These changes lead to diastolic dysfunction and significant atrial stretch. 43 Atrial stretch leads to slow conduction, areas of low voltage denoting atrial scar, decreased sinus node reserve, and pockets of excitability, predisposing to both AF initiation and maintenance. [44] [45] [46] [47] In addition, the negative tracheal pressure that occurs during episodes of apnoea is known to modify the atrial effective refractory period and increase AF inducibility.
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Role of Inflammation in AF and Obstructive Sleep Apnoea
Patients with OSA are known to have enhanced systemic inflammation.
Inflammatory markers including C-reactive protein, tumour necrosis factor-alpha and interleukin-6 are elevated in patients with OSA and are known to correlate with OSA severity. [49] [50] [51] Likewise, there are clinical and histological data to support the role of inflammation in promoting AF. [52] [53] [54] Inflammation seems to correlate with the quantity of atrial scar and remodelling.
Obesity and Adiposity in AF and Obstructive Sleep Apnoea
As mentioned above, an obesity epidemic runs in parallel to the increasing prevalence of AF and OSA. Obesity is a state of sympathetic excess and significant systemic inflammation and several mechanisms have been identified. 55 Hence, obesity plays a central link between OSA and AF. Sustained weight loss abates these pathogenic pathways.
Weight loss consistently reduces OSA severity and improves AF burden, AF symptom scores and potentially reverses cardiac remodelling.
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Negative Thoracic Pressure, Obstructive Sleep Apnoea and AF Pathogenesis
Observations from studies using animal models show that negative intrathoracic pressure (NTP) created by an obstructed upper airway, has the potential to increase AF susceptibility. 58, 59 NTP is associated with a profound shortening of atrial effective refractory period and increases AF susceptibility. Further, recurrent and chronic NTP may lead to atrial remodelling by altering connexin junctions in atrial myocytes leading to conduction abnormalities and AF susceptibility.
Obstructive Sleep Apnoea Treatment and AF Burden
Continuous positive airway pressure (CPAP) is the most common treatment modality for OSA. Multiple small observational studies have assessed the utility of CPAP in reducing AF burden. [60] [61] [62] [63] Although limited by methodology issues and small sample sizes, these studies largely support the view that CPAP therapy improves AF burden. This is independent of the modality used for rhythm control, including antiarrhythmic drug therapy, direct current cardioversion or catheter ablation. [64] [65] [66] In the Outcomes Registry for Better Informed Treatment for Atrial Fibrillation (ORBIT-AF) registry, 1,841 of the 10,132 AF patients had OSA. 63 These patients had worse symptoms and required more hospitalisations. CPAP therapy reduced the risk of transition from paroxysmal to persistent AF (HR 0.66). However, large randomised studies are needed before firm conclusions can be made regarding the effects of CPAP on AF. 
Electrophysiology and Ablation
Clinical Perspective
• The global burden of AF and obstructive sleep apnoea are increasing as the obesity epidemic worsens.
• AF and obstructive sleep apnoea have common risk factors.
• AF and obstructive sleep apnoea are independently associated with adverse cardiovascular outcomes.
• Biological mechanisms link obstructive sleep apnoea to the development of AF.
• Patients with obstructive sleep apnoea have a poor response to catheter ablation of AF.
